Salmon$160 billion investment arm of pharma giant acquires salmon sea lice-zapping firmDeal is a major step for the 12-year-old aquaculture tech group.John Arne Breivik, CEO of Stingray.Photo: Joar Offerdal VatlestadDrew CherryAnders Furuset